Canadian researchers discovered that dichloroacetate, or DCA, a cheap simple drug that has been used for years to treat metabolic disorders, also happens to kill almost all cancers; unfortunately, DCA is not patented, which means that most pharmaeutical companies will have little interest in carrying out clinical trials using the drug. | Harper's Magazine

Sign in to access Harper’s Magazine

Need to create a login? Want to change your email address or password? Forgot your password?

  1. Sign in to Customer Care using your account number or postal address.
  2. Select Email/Password Information.
  3. Enter your new information and click on Save My Changes.

Locked out of your account? Get help here.

Subscribers can find additional help here.

Not a subscriber? Subscribe today!

Get Access to Print and Digital for $23.99.
Subscribe for Full Access
Get Access to Print and Digital for $23.99.

Canadian researchers discovered that dichloroacetate, or DCA, a cheap simple drug that has been used for years to treat metabolic disorders, also happens to kill almost all cancers; unfortunately, DCA is not patented, which means that most pharmaeutical companies will have little interest in carrying out clinical trials using the drug.

Adjust

Canadian researchers discovered that dichloroacetate, or DCA, a cheap simple drug that has been used for years to treat metabolic disorders, also happens to kill almost all cancers; unfortunately, DCA is not patented, which means that most pharmaeutical companies will have little interest in carrying out clinical trials using the drug.

More from

More